Hepatitis B trials in South Korea

1 of 5 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• No phaseNot yet taking people in South Korea
  Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)

  Where

  Seoul

  Age

  20 years to 70 years

  People

  50 worldwide

  Run by

  Arbutus Biopharma Corporation

  See details and how to joinNCT06277037